Coulter Pharmaceutical's P2P Acquisition

Coulter Pharmaceutical raised a round of funding on December 20, 2000. Investors include Corixa.

Coulter Pharmacuetical develops therapeutic antibodies and targeted oncologics to treat cancer.…

Articles about Coulter Pharmaceutical's P2P Acquisition: